Advertisement

Topics

Companies Related to "Study of Effects of L-Arginine in Colitis and Colon Cancer" [Most Relevant Company Matches] RSS

19:24 EDT 17th October 2018 | BioPortfolio

Here are the most relevant search results for "Study of Effects of L-Arginine in Colitis and Colon Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Study Effects Arginine Colitis Colon Cancer" Companies 1–25 of 3,100+

Extremely Relevant

Bandaid Surgery, PC

Laparoscopic colon surgery, also known as band-aid colon surgery, is a revolutionary colorectal surgical technique pioneered and perfected by Dr.David Blumberg, a Board Certified General and Colorectal Surgeon while in the Department of Surgery at the University of Pittsburgh Medical Center. Company Overview: Band-aid colon surgery is a revolutionary colorectal surgical technique pioneered...


PREVEA clinic

Prevea Clinic wants you to stay "50+ and fabulous." Consider scheduling a colonoscopy (colon cancer screening) once every ten years beginning at age 50. If you have a personal or family history of colon cancer, connect with your physician for a personal recommendation. Many insurance plans cover colonoscopy. Up to 90 percent of colon cancers can be prevented by removing colon polyps before they be...

Relevant

Intracel

Intracel is a leading commercial-stage biotechnology company focused on the development of immune therapy to treat cancer. The company’s pipeline includes product development programs in active immunotherapy and fully human monoclonal antibodies. Intracel has completed clinical studies in Colon, Renal and Ovarian carcinoma, as well as Melanoma. Business StrategyRestructured company to focus o...


StopColonCancerNow.com

StopColonCancerNow.com is a community of more than 700 physicians who have joined forces to promote education and awareness about colon cancer screening and prevention. AmSurg, provider of approximately one in every 10 colonoscopies in the United States, launched the campaign in 2009 as part of its commitment to provide the highest level of care and inform...

Report Card Coalition

Launched in 2004, the Colorectal Cancer Legislation Report Card initiative is supported by a coalition that includes American Cancer Society Cancer Action Network, American College of Gastroenterology, American Gastroenterological Association, American Society of Colon and Rectal Surgeons, American Society for Gastrointestinal Endoscopy, the Cancer Support Community, C3: Colorectal Cancer Coalitio...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

Onconome, Inc.

Onconome is dedicated to the discovery, development and commercialization of innovative biomarkers for the early and accurate detection of prostate, colon, bladder and other forms of cancer, including lung, breast, liver, pancreatic and stomach. Early detection is the key to successful treatment. Our serum tests for early detection of prostate and colon cancer and our urine test for bladder cancer...

Colon Cancer Alliance

Cancer Prevention Pharmaceuticals, Inc.

Cancer Prevention Pharmaceuticals, Inc. (CPP) is developing therapeutics designed to reduce the risk of cancer and other diseases. CPP’s pharmaco-prevention approach has been used with success in other disease categories such as cardiovascular, neurovascular, and infectious disease. In addition to the CPP FAP-310 trial, CPP is co-sponsoring with the N...

Alizyme plc

Alizyme is a speciality biopharmaceutical development company, based in Cambridge, UK. We are focused on developing products for the treatment and management of gastrointestinal disorders involving inflammation, such as ulcerative colitis, and motility, such as irritable bowel syndrome, of obesity and related diseases, such as diabetes, and of the gastrointestinal side effects of cancer therapy, s...

Agensys

Agensys, Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers based on its own proprietary targets. The Company has discovered and validated a rich portfolio of novel, clinically relevant cancer targets to 14 different cancer types that have been carefully selected to enable development of new effective therapeutics with fewer and less ...

Intracel Corporation

INTRACEL Corporation is a biopharmaceutical company developing and commercializing cancer vaccines and immunotherapeutic products for cancer and infectious diseases. The company has built a large portfolio of product candidates. Most advanced of which, OncoVAX® , is a vaccine for Stage II colon cancer patients and is currently being marketed and provided on a commercial basis in the Netherlands....

RMEI Medical Education (RMEI) and Crohn's & Colitis Foundation

The Crohn's & Colitis Foundation (the Foundation) is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). The Foundation’s mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundatio...

PreScience Labs, LLC

PreScience is a developmental stage bio-pharmaceutical company focused on the development of anti-cancer drugs. It has successfully completed preclinical mechanistic, in vitro and animal testing using intra-arterial delivery of its proprietary drug PSL-001. The FDA approved immediate enrollment of a Phase I, dose-escalating study, which PreScience intends ...

RC Cancer Centers

Each year thousands of patients from around the world and across the United States turn to RC Cancer Centers seeking a cure for their prostate cancer and learn why they are The Choice for Saving Lives. Founded in 1979, Radiotherapy Centers of Georgia, a division of RC Cancer Centers, has earned a reputation for being one of the country's top cancer treatment and research facilities because of its ...

Squatty Potty

Launched in late 2011, Squatty Potty, LLC, (www.squattypotty.com) has created a safe, natural, simple solution that allows for easier elimination. The Squatty Potty offers a better bathroom experience by aligning the colon in a natural angle for faster, more effective colon evacuation. The Squatty Potty is designed to help assume the squatting position, wh...

Nagourney Cancer Institute

The Nagourney Cancer Institute is a clinical research center that has pioneered the study of human tumor tissue for individualized cancer patient drug selection and has facilitated cancer drug discovery.

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

BioCancell Therapeutics

BioCancell Therapeutics Inc. is a biopharmaceuticals corporation specializing in the development of Targeted Cancer Therapy for the treatment of numerous types of cancer. The Company's proprietary technology constitutes a novel paradigm for the targeted destruction of cancer cells, with no effect on normal surrounding tissue and no observed side effects, a...

Novogen

Novogen's business is in the most pressing area facing medicine in the modern era - that of degenerative diseases and disorders. Cancer Heart disease (stroke, hypertension, coronary artery disease) Osteoporosis Rheumatoid arthritis Inflammatory Bowel Disease (ulcerative colitis, Crohn's Disease) Neurological diseases (Parkinson's Disease, motor neurone disease) Autoimmune diseases (m...

ProCertus BioPharm, Inc.

ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.ProCertus has established proof of concept in animal models for its product candidates, DermX, ProDermaCel™, and OralX, proprietary pharmaceuticals designed to reduce or eliminate the side effects associated with cancer thera...

Neurobehavioral Research Inc

NRI specializes in using EEG, structural MRI and neuropsychological and behavioral assessment to study the effects of drugs and diseases on brain structure and function. NRI also works towards developing new technologies to support this endeavor.

DIAMICS, INC

Diamics mission is to work in partnership with both individual and institutional experts to develop and market cost-effective molecular-based cancer screening and diagnostic systems that will increase long-term survival rates through early detection. Cancers that can be detected earlier by screening account for at least half of all new cancer cases.1 In addition to cervical cancer, these cancers ...

Inex Pharmaceuticals Corporation

INEX Pharmaceuticals Corporation is a biopharmaceutical company that utilizes proprietary drug delivery systems and therapeutic compounds to increase the effectiveness and reduce the side-effects of anti-cancer therapies. INEX's strategy has been to develop technology capable of making anti-cancer drugs more effective and reducing their side-effects, thus giving these drugs a competitive advantage...

CureFAKtor Pharmaceuticals, LLC

CureFAKtor Pharmaceuticals is a biopharmaceutical company focused on the research and development of Focal Adhesion Kinase therapies to prevent or treat cancer. CureFAKtor's investigational and combination therapy products target pancreatic, breast, colon, melanoma, lung and brain oncology disorders. CureFAKtor research is conducted at the Roswell Park Cancer Institute. Additional information abou...


More From BioPortfolio on "Study of Effects of L-Arginine in Colitis and Colon Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks